Role of immunophenotyping in diagnosis of CLL patient at South Egypt Cancer Institute | ||||
| Minia Journal of Medical Research | ||||
| Volume 31, Issue 4, October 2020, Page 71-76 PDF (312.31 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/mjmr.2022.217108 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Rana M. Nagieb1; Hossam El-Sayed A. El- Ashmawy2; Alaa M. Hashim2; Rania Bakry3 | ||||
| 1Department of Clinical pathology, Police Hospital, Assiut, Egypt | ||||
| 2Department of Clinical pathology, Faculty of Medicine, Al-Azhar University, Egypt | ||||
| 3*Department of Clinical pathology, South Egypt Cancer Institute, Assiut University, Egypt | ||||
| Abstract | ||||
| Objective: To determine the role of immunophenotyping in chronic lymphocytic leukemia (CLL) patients at South Egypt Cancer Institute (SECI). Methodology: This study was carried out in Department of Clinical pathology, South Egypt Cancer Institute, from December 2017 to July 2019. We used SECI Flowcytometry lab 4 color for diagnosis. Results: 37 patients were included in our study with CLL and 30 apparently healthy control group. For the both groups we performed: CBC, BM aspiration, BM biopsy and immunophenotyping. The mean age in CLL group was (55.92± 9.02) years. while the mean age in control group was (38.37 ± 14.08) years . Conclusion: Immunophenotyping has a great role in CLL diagnosis. | ||||
| Keywords | ||||
| CLL; BM | ||||
|
Statistics Article View: 84 PDF Download: 101 |
||||
